Althea Group Holdings Limited (AGH.AX)
AUD 0.03
(0.0%)
AUD 0.03
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -28.56 Million AUD | -182.64% |
| 2023 | -10.23 Million AUD | 2.39% |
| 2022 | -9.07 Million AUD | 25.13% |
| 2021 | -12.84 Million AUD | -19.92% |
| 2020 | -13.21 Million AUD | -29.44% |
| 2019 | -8.62 Million AUD | -359308.33% |
| 2018 | 2400.00 AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -5.31 Million AUD | 0.0% |
| 2024 Q4 | -4.16 Million AUD | 0.0% |
| 2024 FY | - AUD | 9.26% |
| 2023 Q4 | -2.93 Million AUD | 0.0% |
| 2023 FY | - AUD | 2.39% |
| 2023 Q2 | -6.84 Million AUD | 0.0% |
| 2022 FY | - AUD | 25.13% |
| 2022 Q4 | -4.23 Million AUD | 0.0% |
| 2022 Q2 | -5.78 Million AUD | 0.0% |
| 2021 FY | - AUD | -19.92% |
| 2021 Q2 | -5.99 Million AUD | 0.0% |
| 2021 Q4 | -7.3 Million AUD | 0.0% |
| 2020 FY | - AUD | -29.44% |
| 2020 Q2 | -6.11 Million AUD | 0.0% |
| 2020 Q4 | -4.52 Million AUD | 0.0% |
| 2019 Q3 | -2.15 Million AUD | 9.02% |
| 2019 FY | - AUD | -359308.33% |
| 2019 Q4 | -6.15 Million AUD | -185.58% |
| 2019 Q2 | -2.36 Million AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q2 | 125 Thousand AUD | 101.61% |
| 2018 Q1 | 62 Thousand AUD | 0.0% |
| 2018 Q4 | -122.6 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cann Group Limited | -35.53 Million AUD | 19.628% |
| ECS Botanics Holdings Ltd | 3.22 Million AUD | 984.709% |
| Ecofibre Limited | -38.34 Million AUD | 25.514% |
| Elixinol Wellness Limited | -6.8 Million AUD | -319.644% |
| Hygrovest Limited | -1.1 Million AUD | -2489.393% |
| IDT Australia Limited | -5.13 Million AUD | -456.419% |
| Invion Limited | -4.57 Million AUD | -524.728% |
| Little Green Pharma Ltd | -4.64 Million AUD | -515.099% |
| Live Verdure Ltd | -12.51 Million AUD | -128.278% |
| Medical Developments International Limited | -29.44 Million AUD | 3.006% |
| Vitura Health Limited | 7.07 Million AUD | 503.617% |
| Vita Life Sciences Limited | 13.09 Million AUD | 318.056% |